Matt works closely with management teams across the Midlands looking to grow their business and is responsible for identifying ambitious teams that would benefit from the support of a private equity partner.
Since joining LDC in 2012, Matt has invested more than £300million across a number of high-profile businesses in the UK, including Harper James, Pace Group, Kingswood ,The NEC Group, BSG, Prism Medical, Stuart Turner, Eley, SMH Fleet, Centiq, Ross Trustees, and CitySprint, averaging over 3x return on realised investments.
Matt is currently Investor Director on the Boards of Pace Group and Kingswood Healthcare and also sits on the UK & European Capital Committee for the BVCA which represents the interests of the BVCA’s mid-market members. Previous Board positions include Stuart Turner, Cardel, Kee Safety, Prism Medical, and CitySprint.
Matt recently spoke with private equity news title Real Deals about LDC’s track record in the healthcare sector – read more here.
After graduating from Nottingham Trent University with a First Class Degree in Accounting & Finance and qualifying as a Chartered Accountant, Matt gained eight years of corporate finance experience with PwC and Alantra, working in the UK and North America.
LDC trusted my vision for the Stuart Turner group which gave me the platform and capital to execute on the M&A strategy. Matt was also right alongside me in the thick of the negotiations and deal assessment and the VCP team provided valuable pre and post deal integration support – it felt like a true team effort”.
ESG Guide
ESG has become a crucial component for companies and investors partnering for growth. Here Matt Newbold offers advice to management teams seeking funding.
READ MORE
Awards
Private Equity Team of the Year
West Midlands Rainmaker Awards 2025
Funder of the Year
Midlands Dealmakers Awards 2023